Indianapolis, IN, United States of America

Michael Dean Kinnick

This inventor holds 20 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Eli Lilly and Company. Active years: 1997-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Dean Kinnick. Retrieved from https://idiyas.com/inventor/michael-dean-kinnick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 40.0

Average Co-Inventor Count = 7.9

ph-index = 9

Forward Citations = 164(Granted Patents)


Company Filing History:


Years Active: 1997-2007

Loading Chart...
Areas of Expertise:
Melanin Concentrating Hormone
Obesity Treatment
Diabetes Management
sPLA2 Inhibitors
Cyclohept[b]indole
Tricyclic Compounds
Glycoprotein IIb/IIIa
Cell Adhesion Inhibitors
Pharmaceutical Chemistry
Indole Derivatives
Antagonists
Compounds
20 patents (USPTO):Explore Patents

Title: The Inventor Michael Dean Kinnick

Introduction: Michael Dean Kinnick is a prolific inventor based in Indianapolis, IN (US) known for his groundbreaking contributions to various industries.

Latest Patents: Michael Dean Kinnick holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: Throughout his career, Michael Dean Kinnick has demonstrated a keen ability to transform creative concepts into tangible inventions that have made a significant impact in the market.

Collaborations: Michael Dean Kinnick has collaborated with leading companies, research institutions, and universities to further develop and commercialize his inventions, solidifying his reputation as a visionary inventor.

Conclusion: Michael Dean Kinnick's passion for innovation and his relentless pursuit of excellence continue to drive his success in the world of inventions, making him a respected figure in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…